Polio survivor joins Colorado’s new pro-vaccine group, created as federal guidelines upended - Colorado Public Radio
Google News • 1/14/2026 – 1/16/2026
Summary
A polio survivor has joined a new pro-vaccine group in Colorado. This group was created in response to changes in federal guidelines.
Advertisement
Lindy Score Breakdown (V4.2)
80d
Age
1
Sources
from cluster
1883
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1883/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1883/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 80 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Stat News • 1 day ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 2 days ago
STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Stat News • 2 days ago
EPA to put microplastics on study list of contaminants in drinking water
Stat News • 2 days ago
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • 1 day ago
Opinion: Medical misinformation wins when patients can’t see their doctors
Stat News • 2 days ago
Thursday was World Autism Awareness Day. HHS celebrated with…a workout?
Stat News • 1 day ago
Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Stat News • 1 day ago
Biotech investors’ plea to Trump, and a busy M&A week
Stat News • 2 days ago
STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago